Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 18653608 | TRACE ELEMENT COMPOSITIONS, METHODS OF MAKING AND USE | May 2024 | October 2024 | Allow | 5 | 1 | 0 | No | No |
| 18511294 | SYNTHETIC ENAMEL AND USES THEREOF | November 2023 | March 2025 | Allow | 16 | 3 | 0 | No | No |
| 18183415 | DISPENSING METHOD FOR PRODUCING DISSOLVABLE UNIT DOSE FILM CONSTRUCTS | March 2023 | December 2024 | Allow | 21 | 1 | 0 | No | No |
| 18112852 | TOPICAL COMPOSITION FOR DESTROYING, in vivo, AN EXTERNAL HYPERPLASTIC TISSUE, SUCH AS, BUT NOT LIMITED TO, A VIRAL SKIN LESION, SUCH AS, BUT NOT LIMITED TO, A VIRAL WART | February 2023 | October 2024 | Allow | 20 | 2 | 0 | No | Yes |
| 18162479 | TOPICAL INSTANT SMOOTHING AND COLORING COMPOSITIONS FOR THE SKIN | January 2023 | July 2025 | Abandon | 29 | 2 | 0 | No | No |
| 18074838 | Oral Care Compositions Containing A Gel Network Phase | December 2022 | October 2024 | Allow | 22 | 1 | 0 | No | No |
| 17987336 | TOOTH ANTI-STAINING COMPOSITION, KIT AND METHOD OF USING THE SAME | November 2022 | April 2025 | Abandon | 29 | 3 | 0 | No | No |
| 18046101 | VAGINAL INSERTED ESTRADIOL PHARMACEUTICAL COMPOSITIONS AND METHODS | October 2022 | February 2025 | Abandon | 28 | 1 | 0 | No | No |
| 17933483 | AQUEOUS EYEBROW COSMETIC AND EYEBROW COSMETIC PRODUCT | September 2022 | November 2024 | Allow | 26 | 2 | 0 | Yes | No |
| 17932547 | ANTI-WRINKLE COSMETIC COMPOSITION, COMPOSITION SYSTEM AND METHOD FOR COSMETIC SKIN TREATMENT | September 2022 | February 2025 | Abandon | 29 | 1 | 0 | No | No |
| 17891646 | PALMITOYL TETRAPEPTIDE-20 CONJUGATED NANOSILVER PARTICLE AND USE THEREOF | August 2022 | December 2024 | Abandon | 28 | 1 | 0 | No | No |
| 17864646 | VEGAN SEMI-SOLID COSMETIC COMPOSITION | July 2022 | March 2025 | Allow | 32 | 4 | 0 | No | No |
| 17826494 | NATURAL TISSUE SCAFFOLDS AS TISSUE FILLERS | May 2022 | January 2025 | Abandon | 32 | 1 | 0 | No | No |
| 17712764 | TOPICAL COPPER ION TREATMENTS AND METHODS OF MAKING TOPICAL COPPER ION TREATMENTS FOR USE IN VARIOUS ANATOMICAL AREAS OF THE BODY | April 2022 | August 2024 | Allow | 28 | 1 | 0 | No | No |
| 17630205 | 1,8-CINEOL COATED IMPLANTS | January 2022 | May 2025 | Abandon | 40 | 0 | 1 | No | No |
| 17581031 | FUNCTIONAL FOODS COMPRISING DIAMINE OXIDASE AND USES THEREOF | January 2022 | August 2024 | Allow | 31 | 1 | 0 | No | No |
| 17571179 | Oral Care Compositions and Methods of Use | January 2022 | August 2024 | Allow | 31 | 1 | 0 | No | No |
| 17550558 | CHEMICAL MEMBRANE COMPLEX REPAIR SOLUTION AND METHOD OF USING THE SAME | December 2021 | June 2025 | Abandon | 42 | 2 | 1 | No | No |
| 16623742 | COSMETIC PRODUCT USING PHOTOCHROMIC POWDER AND METHOD OF MANUFACTURING THE SAME | November 2021 | May 2025 | Abandon | 60 | 0 | 1 | No | No |
| 17516861 | BIODEGRADABLE FUNCTIONAL POLYCARBONATE NANOPARTICLE CARRIES FOR DELIVERING MOLECULAR CARGO | November 2021 | August 2024 | Allow | 34 | 2 | 0 | Yes | No |
| 17515263 | VAGINAL INSERTED ESTRADIOL PHARMACEUTICAL COMPOSITIONS AND METHODS | October 2021 | March 2025 | Abandon | 41 | 1 | 0 | No | No |
| 17506939 | POLYMER COMPOSITE FOR CONTROLLED RELEASE OF AN AGENT | October 2021 | December 2024 | Abandon | 37 | 0 | 1 | No | No |
| 17440742 | FLEXIBLE METAL PATCH HAVING ANTIOXIDANT ACTIVITY AND BRIGHTENING EFFECT AND METHOD FOR USING SAME | September 2021 | January 2025 | Abandon | 40 | 2 | 0 | No | No |
| 17444510 | ORGANIC COUNTERANION CO-ASSEMBLY STRATEGY FOR THE FORMATION OF CYCLODEXTRIN-CONTAINING HYBRID FRAMEWORKS | August 2021 | July 2024 | Allow | 35 | 3 | 0 | No | No |
| 17390946 | THERMAL CONTROL OF HAIR COLOR-ALTERING COMPOSITIONS | July 2021 | July 2024 | Allow | 36 | 2 | 0 | Yes | No |
| 17380884 | ANTIMICROBIAL COSMETIC PREPARATION | July 2021 | October 2024 | Abandon | 39 | 3 | 0 | No | No |
| 17372315 | LONG-ACTING POLYMERIC DELIVERY SYSTEMS | July 2021 | March 2025 | Abandon | 44 | 2 | 0 | No | No |
| 17419527 | ORAL ARTICLES AND METHODS OF USE | June 2021 | April 2025 | Allow | 45 | 6 | 0 | No | No |
| 17315584 | SELF-EMULSIFYING COMPOSITION OF OMEGA3 FATTY ACID | May 2021 | December 2024 | Abandon | 43 | 1 | 0 | No | No |
| 17308079 | Oral Care Compositions Comprising Dicarboxylic Acid | May 2021 | February 2025 | Abandon | 45 | 4 | 0 | No | No |
| 17245525 | Oral Care Composition Comprising Cuttlefish Bone Powder and Uses Thereof | April 2021 | December 2024 | Abandon | 43 | 1 | 0 | No | No |
| 17238263 | ORODISPERSIBLE FILMS HAVING QUICK DISSOLUTION TIMES FOR THERAPEUTIC AND FOOD USE | April 2021 | December 2024 | Abandon | 43 | 1 | 0 | No | No |
| 17232020 | FULL ARCH DENTAL TREATMENT DEVICES AND SYSTEMS | April 2021 | January 2025 | Abandon | 45 | 2 | 0 | No | No |
| 17226936 | METHODS OF TREATMENT USING TOPICAL COPPER ION FORMULATIONS | April 2021 | February 2025 | Abandon | 47 | 10 | 0 | Yes | No |
| 17279365 | PHOTONIC BARRIER FOR TOPICAL USE, COMPRISING BISMUTH OXIDE COLLOIDS | March 2021 | February 2025 | Allow | 46 | 4 | 0 | Yes | No |
| 17195267 | TRANSDERMAL THERAPEUTIC SYSTEM CONTAINING ASENAPINE | March 2021 | June 2024 | Allow | 40 | 1 | 0 | No | No |
| 17165897 | L-SERINE COMPOSITIONS, METHODS AND USES FOR TREATING NEURODEGENERATIVE DISEASES AND DISORDERS | February 2021 | March 2025 | Allow | 50 | 3 | 0 | No | No |
| 17130405 | COMPOSITION AND METHOD FOR INHIBITING PLATELET AGGREGATION | December 2020 | April 2025 | Abandon | 52 | 2 | 1 | No | Yes |
| 17253395 | COMPOSITION WITH LONG-LASTING CONCEALING EFFECTS | December 2020 | January 2025 | Allow | 49 | 8 | 0 | No | No |
| 17120197 | DENTAL CARE CANNABIS DEVICE AND USE THEREOF | December 2020 | March 2025 | Abandon | 51 | 6 | 0 | No | No |
| 17056139 | Docetaxel palmitate liposome and preparation method thereof | November 2020 | April 2024 | Abandon | 41 | 4 | 1 | No | No |
| 17091573 | BIOACTIVE GLASS COMPOSITIONS AND DENTIN HYPERSENSITIVITY REMEDIATION | November 2020 | October 2024 | Abandon | 48 | 2 | 0 | No | No |
| 17065302 | SODIUM BICARBONATE IN SITU CONVERSION DRIVEN TRANSDERMAL DELIVERY OF AMINE DRUG | October 2020 | January 2025 | Abandon | 51 | 2 | 0 | No | No |
| 16990739 | Solid Dosage Form | August 2020 | September 2024 | Allow | 49 | 2 | 0 | No | Yes |
| 16961080 | ANTI-ADHESION COMPOSITION | July 2020 | March 2025 | Abandon | 56 | 6 | 1 | No | Yes |
| 16897131 | CHITOSAN AND POLYETHYLENE GLYCOL COPOLYMERS AND METHODS AND DEVICES FOR USING SAME FOR SEALING A VASCULAR PUNCTURE | June 2020 | February 2025 | Abandon | 56 | 4 | 1 | No | Yes |
| 16797580 | METHODS OF TREATMENT USING TOPICAL COPPER ION FORMULATIONS | February 2020 | March 2025 | Allow | 60 | 11 | 1 | Yes | Yes |
| 16694739 | NON-SORPTIVE OR MINIMALLY SORPTIVE DISINFECTANT WIPES | November 2019 | February 2025 | Allow | 60 | 6 | 0 | Yes | Yes |
| 16385240 | BONE SUBSTITUTE COMPOSITION AND RELATED METHODS | April 2019 | October 2024 | Abandon | 60 | 9 | 1 | No | No |
| 16334247 | Polymer-Free Drug Eluting Vascular Stents | March 2019 | July 2025 | Allow | 60 | 8 | 0 | Yes | Yes |
| 16220320 | BONE SUBSTITUTE MATERIAL | December 2018 | March 2020 | Allow | 15 | 2 | 0 | No | No |
| 16097977 | COATED IMPLANTS FOR LONG-TERM CONTROLLED RELEASE OF ANTIBODY THERAPEUTICS | October 2018 | October 2024 | Allow | 60 | 6 | 0 | Yes | Yes |
| 16006721 | VAGINAL INSERTED ESTRADIOL PHARMACEUTICAL COMPOSITIONS AND METHODS | June 2018 | March 2025 | Abandon | 60 | 7 | 1 | No | Yes |
| 15975733 | VAGINAL INSERTED ESTRADIOL PHARMACEUTICAL COMPOSITIONS AND METHODS | May 2018 | February 2025 | Abandon | 60 | 9 | 0 | No | Yes |
| 15820393 | BONE IMPLANT AND SYSTEMS AND COATINGS FOR THE CONTROLLABLE RELEASE OF ANTIMICROBIAL METAL IONS | November 2017 | August 2018 | Allow | 9 | 0 | 0 | No | No |
| 15530015 | System and method for reducing plaque on teeth | November 2016 | August 2018 | Allow | 21 | 1 | 0 | No | No |
| 15283778 | COMPOSITION COMPRISING DIAMINE OXIDASE FOR USE IN THE TREATMENT OR PREVENTION OF FIBROMYALGIA OR CHRONIC FATIGUE SYNDROME | October 2016 | September 2024 | Allow | 60 | 6 | 0 | Yes | Yes |
| 15270352 | METHODS AND SYSTEMS FOR TREATING MEDICAL DEVICES AND FLUIDS | September 2016 | January 2022 | Abandon | 60 | 5 | 0 | No | Yes |
| 15105495 | METHOD FOR PRODUCING AN ANTIMICROBIAL COMPOSITE MATERIAL AND ANTIMICROBIAL COMPOSITE MATERIAL | August 2016 | October 2024 | Allow | 60 | 13 | 1 | Yes | No |
| 15149341 | Heat Treated Precipitated Silica | May 2016 | January 2018 | Allow | 20 | 3 | 0 | Yes | No |
| 14914120 | ORAL CARE COMPOSITION | February 2016 | August 2017 | Allow | 18 | 2 | 0 | Yes | No |
| 14903803 | LIPOSOMAL DRUG DELIVERY SYSTEM FOR BONE CEMENTS | January 2016 | September 2017 | Allow | 20 | 2 | 0 | Yes | No |
| 14658352 | ADSORPTION METHOD, ADSORPTION SEPARATION METHOD, AND DRUG DELIVERY CARRIER | March 2015 | April 2017 | Allow | 25 | 2 | 0 | Yes | No |
| 14569545 | BIOABSORBABLE SUBSTRATES AND SYSTEMS THAT CONTROLLABLY RELEASE ANTIMICROBIAL METAL IONS | December 2014 | February 2015 | Allow | 2 | 0 | 0 | No | No |
| 14547875 | DISSOLVABLE DIETARY SUPPLEMENT STRIP AND METHODS FOR USING THE SAME | November 2014 | July 2016 | Allow | 20 | 2 | 0 | No | No |
| 14121414 | System and method for reducing plaque on teeth | September 2014 | September 2016 | Allow | 24 | 6 | 0 | Yes | No |
| 14379692 | ACACIA GUM ADHESIVE WITH CALCIUM CARBONATE FOR ORAL ADHERING DISCS | August 2014 | July 2017 | Allow | 35 | 4 | 0 | No | Yes |
| 14371106 | Polyherbal Composition for Skin Care | July 2014 | October 2016 | Allow | 28 | 4 | 0 | Yes | No |
| 14364692 | Oral Care Composition for Enhancing Delivery of Active Agents to Mucosa/Soft Oral Tissue and Tooth Surfaces in the Oral Cavity | June 2014 | May 2016 | Allow | 23 | 2 | 0 | No | No |
| 14249456 | METHOD FOR PREPARING BIOCOMPATIBLE AND BIODEGRADABLE BIOMATERIALS BASED ON COLLAGEN AND GRANULES OF HYDROXYAPATITE/BETA-TRICALCIUM PHOSPHATE FOR USE IN SURGERY, AND BIOMATERIALS THUS OBTAINED | April 2014 | April 2016 | Allow | 25 | 2 | 0 | No | No |
| 14162090 | MOUTHWASH COMPOSITION | January 2014 | June 2015 | Allow | 17 | 1 | 0 | No | No |
| 14088768 | THERAPEUTIC DELIVERY SYSTEM | November 2013 | August 2014 | Allow | 9 | 1 | 0 | Yes | No |
| 14075902 | POLYMERIC FILM FOR AGRICULTURAL PRODUCT STORAGE, CONTAINERS MADE THEREFROM AND RELATED METHODS OF AGRICULTURAL PRODUCT STORAGE | November 2013 | January 2016 | Allow | 26 | 1 | 0 | No | No |
| 13975562 | DENTAL PREPARATION DELIVERY SYSTEM | August 2013 | June 2014 | Allow | 9 | 1 | 1 | Yes | No |
| 13835819 | TREATED SILICAS AND METAL SILICATES FOR IMPROVED CLEANING IN DENTIFRICE | March 2013 | July 2015 | Allow | 28 | 2 | 0 | No | No |
| 13834722 | ROOFING GRANULES | March 2013 | April 2016 | Allow | 37 | 4 | 0 | Yes | No |
| 13756836 | PROCESS FOR ORAL CARE MATERIAL TASTE AND/OR ODOR IMPROVEMENT | February 2013 | April 2015 | Allow | 27 | 1 | 1 | No | No |
| 13705552 | Compositions Comprising Non Steroidal Anti-inflammatory Drugs and Methods for Use Thereof | December 2012 | March 2015 | Allow | 27 | 2 | 0 | Yes | No |
| 13633342 | BIOMEDICAL IMPLANTS COMPRISING SURFACE-MODIFIED CERAMIC PARTICLES AND BIODEGRADABLE STEREO COMPLEX POLYMERS, ITS USE FOR SUPPRESSING INFLAMMATION AND IMPROVEMENT OF MECHANICAL PROPERTY, AND PREPARATION METHOD THEREOF | October 2012 | August 2014 | Allow | 23 | 1 | 1 | No | No |
| 13583682 | STRUCTURED NON-AQUEOUS GEL-FORM CARRIER COMPOSITION | September 2012 | September 2015 | Allow | 36 | 3 | 1 | Yes | Yes |
| 13580918 | DIMENSIONALLY STABLE NONWOVEN FIBROUS WEBS AND METHODS OF MAKING AND USING THE SAME | August 2012 | March 2014 | Allow | 19 | 2 | 0 | Yes | No |
| 13564823 | PROCESS FOR SURFACTANT TASTE AND/OR ODOR IMPROVEMENT | August 2012 | September 2013 | Allow | 13 | 1 | 0 | No | No |
| 13574170 | INSERTION MATERIAL INTENDED FOR WIDENING THE GINGIVAL CREVICE | July 2012 | May 2015 | Allow | 34 | 3 | 0 | No | No |
| 13552196 | TEETH-WHITENING GEL | July 2012 | March 2014 | Allow | 20 | 2 | 0 | Yes | No |
| 13515922 | METHOD OF REDUCING THE ODOUR OF SULPHUR-BOUND PRODUCTS | July 2012 | March 2015 | Allow | 33 | 3 | 1 | No | No |
| 13492954 | INGESTIBLE ORAL CARE COMPOSITION AND METHOD THEREFOR | June 2012 | March 2014 | Allow | 22 | 2 | 0 | Yes | No |
| 13486382 | NANOSTRUCTURED MATERIAL FORMULATED WITH BONE CEMENT FOR EFFECTIVE ANTIBIOTIC DELIVERY | June 2012 | June 2015 | Allow | 37 | 4 | 0 | No | No |
| 13505002 | BIOEQUIVALENT FORMULATION OF EFAVIRENZ | May 2012 | June 2015 | Allow | 37 | 4 | 1 | No | Yes |
| 12976820 | METHODS TO PREVENT CYTOTOXICITY USING N-ACETYL-CYSTEINE | December 2010 | March 2013 | Allow | 26 | 1 | 1 | Yes | No |
| 12902594 | Therapeutic Delivery System | October 2010 | June 2013 | Allow | 32 | 4 | 1 | Yes | No |
| 12818692 | DISSOLVABLE DIETARY SUPPLEMENT STRIP AND METHODS FOR USING THE SAME | June 2010 | August 2014 | Allow | 50 | 3 | 1 | No | No |
| 12594230 | REMINERALIZATION PROMOTER AND COMPOSITION FOR ORAL CAVITY | October 2009 | March 2015 | Allow | 60 | 4 | 0 | Yes | Yes |
| 12288708 | Diamond, precious and semi-precious dust polishing agent for dental veneers and teeth | October 2008 | March 2012 | Abandon | 40 | 6 | 0 | Yes | No |
| 11985944 | Tooth whitener and maintenance with bleach bumpers | November 2007 | July 2012 | Abandon | 56 | 3 | 1 | Yes | No |
| 11918168 | Foam Strip for the Delivery of Oral Care Compositions | November 2007 | January 2014 | Allow | 60 | 3 | 1 | Yes | No |
| 11745212 | HARDENABLE THERMALLY RESPONSIVE COMPOSITIONS | May 2007 | July 2014 | Allow | 60 | 4 | 1 | No | Yes |
| 11414435 | Patches for teeth whitening | April 2006 | September 2013 | Allow | 60 | 3 | 0 | Yes | No |
| 10939163 | Multi-layer transdermal drug delivery device | September 2004 | March 2014 | Allow | 60 | 5 | 1 | Yes | Yes |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner LIU, TRACY.
With a 57.1% reversal rate, the PTAB has reversed the examiner's rejections more often than affirming them. This reversal rate is in the top 25% across the USPTO, indicating that appeals are more successful here than in most other areas.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 40.9% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is above the USPTO average, suggesting that filing an appeal can be an effective strategy for prompting reconsideration.
✓ Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.
✓ Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.
Examiner LIU, TRACY works in Art Unit 1614 and has examined 97 patent applications in our dataset. With an allowance rate of 66.0%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 36 months.
Examiner LIU, TRACY's allowance rate of 66.0% places them in the 19% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.
On average, applications examined by LIU, TRACY receive 3.06 office actions before reaching final disposition. This places the examiner in the 96% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.
The median time to disposition (half-life) for applications examined by LIU, TRACY is 36 months. This places the examiner in the 16% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.
Conducting an examiner interview provides a +37.8% benefit to allowance rate for applications examined by LIU, TRACY. This interview benefit is in the 88% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.
When applicants file an RCE with this examiner, 14.6% of applications are subsequently allowed. This success rate is in the 5% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.
This examiner enters after-final amendments leading to allowance in 35.6% of cases where such amendments are filed. This entry rate is in the 45% percentile among all examiners. Strategic Recommendation: This examiner shows below-average receptiveness to after-final amendments. You may need to file an RCE or appeal rather than relying on after-final amendment entry.
When applicants request a pre-appeal conference (PAC) with this examiner, 66.7% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 50% percentile among all examiners. Note: Pre-appeal conferences show below-average success with this examiner. Consider whether your arguments are strong enough to warrant a PAC request.
This examiner withdraws rejections or reopens prosecution in 68.2% of appeals filed. This is in the 48% percentile among all examiners. Of these withdrawals, 40.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows below-average willingness to reconsider rejections during appeals. Be prepared to fully prosecute appeals if filed.
When applicants file petitions regarding this examiner's actions, 41.4% are granted (fully or in part). This grant rate is in the 42% percentile among all examiners. Strategic Note: Petitions show below-average success regarding this examiner's actions. Ensure you have a strong procedural basis before filing.
Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 0% percentile). This examiner rarely makes examiner's amendments compared to other examiners. You should expect to make all necessary claim amendments yourself through formal amendment practice.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 0% percentile). This examiner rarely issues Quayle actions compared to other examiners. Allowances typically come directly without a separate action for formal matters.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.